# OnCo record nct07474727 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07474727/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07474727", "NCT07474727" ;
  schema:name "A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer"@en ;
  schema:description "A phase 2 trial of FLOT, Bevacizumab, Cetuximab in colorectal cancer, run by Multitude Therapeutics Inc., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07474727/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07474727> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2026-04-29" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/antiangiogenic/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/flot/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/folfiri/>, <https://onco.cc/drugs/capox/> ;
  onco:companies <https://onco.cc/companies/multitude-therapeutics/> .